Health Empire Corporation PCL (BKK:HEALTH)
Thailand · Delayed Price · Currency is THB 0.4000
-0.0300 (-6.98%)
At close: Feb 10, 2026
BKK:HEALTH Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 97.8 | 41.82 | 20.63 | 107.74 | 108.28 | 105.58 |
Other Revenue | 0 | 3.99 | 4.43 | 10.29 | 16.1 | 3.36 |
| 97.8 | 45.81 | 25.07 | 118.03 | 124.38 | 108.94 | |
Revenue Growth (YoY) | 163.53% | 82.75% | -78.76% | -5.10% | 14.17% | -29.09% |
Cost of Revenue | 50 | 22.45 | 9.78 | 60.44 | 50.75 | 71.13 |
Gross Profit | 47.8 | 23.36 | 15.28 | 57.59 | 73.62 | 37.81 |
Selling, General & Admin | 53.23 | 63.13 | 76.56 | 138.51 | 133.43 | 64.94 |
Operating Expenses | 53.23 | 63.13 | 76.56 | 138.51 | 133.43 | 64.94 |
Operating Income | -5.43 | -39.77 | -61.28 | -80.92 | -59.8 | -27.13 |
Interest Expense | -1.04 | -0.94 | -2.49 | -2.37 | -1.89 | -1.43 |
Earnings From Equity Investments | -1.99 | 2.59 | 13.22 | -0.13 | - | - |
EBT Excluding Unusual Items | -8.46 | -38.12 | -50.55 | -83.42 | -61.7 | -28.56 |
Impairment of Goodwill | -189.01 | -419.63 | -212.81 | -422.29 | - | - |
Gain (Loss) on Sale of Investments | - | -1.51 | -3.42 | -9 | - | - |
Gain (Loss) on Sale of Assets | 0.01 | 0.01 | 0.04 | 39.46 | 0.65 | 0.19 |
Pretax Income | -197.46 | -459.25 | -266.74 | -475.25 | -61.05 | -28.37 |
Income Tax Expense | -0.75 | 0.28 | - | 0.58 | 0.37 | - |
Earnings From Continuing Operations | -196.71 | -459.53 | -266.74 | -475.84 | -61.42 | -28.37 |
Minority Interest in Earnings | -8.27 | 1.26 | 2.27 | 18.55 | 16.21 | - |
Net Income | -204.97 | -458.27 | -264.47 | -457.29 | -45.21 | -28.37 |
Net Income to Common | -204.97 | -458.27 | -264.47 | -457.29 | -45.21 | -28.37 |
Shares Outstanding (Basic) | 421 | 392 | 383 | 360 | 213 | 76 |
Shares Outstanding (Diluted) | 421 | 392 | 383 | 360 | 213 | 76 |
Shares Change (YoY) | 9.58% | 2.37% | 6.49% | 69.17% | 180.61% | - |
EPS (Basic) | -0.49 | -1.17 | -0.69 | -1.27 | -0.21 | -0.37 |
EPS (Diluted) | -0.49 | -1.17 | -0.69 | -1.27 | -0.21 | -0.37 |
Free Cash Flow | 0.55 | -46.97 | -22.97 | -74.37 | -89.83 | -11.14 |
Free Cash Flow Per Share | 0.00 | -0.12 | -0.06 | -0.21 | -0.42 | -0.15 |
Gross Margin | 48.88% | 50.99% | 60.96% | 48.79% | 59.19% | 34.71% |
Operating Margin | -5.55% | -86.82% | -244.49% | -68.56% | -48.08% | -24.90% |
Profit Margin | -209.59% | -1000.41% | -1055.14% | -387.43% | -36.35% | -26.04% |
Free Cash Flow Margin | 0.56% | -102.53% | -91.65% | -63.01% | -72.23% | -10.23% |
EBITDA | 5.39 | -29.9 | -48.97 | -59.52 | -46.03 | -23.54 |
EBITDA Margin | 5.51% | -65.26% | -195.37% | -50.43% | -37.00% | -21.61% |
D&A For EBITDA | 10.81 | 9.87 | 12.31 | 21.4 | 13.78 | 3.59 |
EBIT | -5.43 | -39.77 | -61.28 | -80.92 | -59.8 | -27.13 |
EBIT Margin | -5.55% | -86.82% | -244.49% | -68.56% | -48.08% | -24.90% |
Revenue as Reported | 97.81 | 45.82 | 25.11 | 159.81 | 125.03 | 109.13 |
Advertising Expenses | - | 3.6 | 2.01 | 1.9 | 14.16 | 1.84 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.